dr. traina on parp inhibition in brca-mutated breast cancer
Published 6 years ago • 446 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
5:18
parp inhibitors for brca-mutated tnbc
-
6:20
parp inhibitors for brca-mutated tnbc
-
1:27
dr. litton on the impact of parp inhibitors in breast cancer
-
5:19
parp inhibitors for brca-associated tnbc
-
3:31
distinguishing between parp inhibitors in breast cancer
-
3:58
brca breast cancer: the advent of parp inhibitors
-
0:25
banu arun, md, on parp inhibitors in brca positive metastatic breast cancer
-
12:07
parp inhibitors in brca1/2-mutated patients in prostate cancer
-
1:10
dr. tripathy on impact of olaparib approval in brca-positive breast cancer
-
0:58
dr. litton on the embraca trial in advanced brca1/2 breast cancer
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
1:16
parp inhibitors improve outcomes, qol in breast cancer
-
4:19
treating brca breast cancer with parp inhibition
-
0:27
parp inhibitors #short
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
3:50
debu tripathy, md, describes the evolving role of parp inhibitors in breast cancer patients
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer